Zydus Lifesciences gets USFDA nod for generic acne-treating drug

Zydus Lifesciences received final approval from the US health regulator for its generic antibiotic Minocycline Hydrochloride extended-release tablets used for treatment of moderate to severe acne, the company said in a regulatory filing on Monday.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/oJeg3h1
via IFTTT